期刊文献+

羧甲基壳聚糖超小超顺磁氧化铁纳米粒在大鼠体内的药动学特点及组织分布 被引量:1

Pharmacokinetics, Tissue Distribution of O-Carboxymethyl Chitosans Ultrasmall Superparamagnetic Iron Oxide Nanoparticles in Rats
原文传递
导出
摘要 目的考察羧甲基壳聚糖超小超顺磁氧化铁纳米粒(O-carboxymethyl chitosans ultrasmall superparamagnetic iron oxide nanoparticles,OCMCS-USPIO-NPs)在SD大鼠体内的药动学特征及组织分布,为其临床应用提供依据。方法 SD大鼠随机分为生理盐水组、OCMCS-USPIO-NPs组和葡聚糖超顺磁氧化铁纳米粒组(dextran-SPIO-NPs),原子分光光度法测定血浆和心、肝、脾、肺和肾等组织的铁含量,DAS药动学软件对血药浓度-时间数据处理,求得OCMCS-USPIO-NPs组和dextran-SPIO-NPs组在大鼠体内的主要药动学参数;绘制组织内铁含量-时间曲线结合普鲁士蓝染色,比较OCMCS-USPIO-NPs和Dextran-SPIO-NPs在大鼠体内组织分布特点。结果 OCMCS-USPIO-NPs组和dextran-SPIO-NPs组的主要药动学参数(AUC,MRT,t1/2,CL,V2,差异显著(P<0.05),且OCMCS-USPIO-NPs组t1/2>7 h;OCMCS-USPIO-NPs组在肝、脾和肺的组织分布浓度显著低于dextran-SPIO-NPs组。结论 OCMCS-USPIO-NPs能逃避网状内皮系统吞噬,具有长循环作用。 OBJECTIVE To study pharmacokinetics features and tissue distribution of OCMCS-USPIO-NPs in SD rats in vivo to provide evidence for their clinical use in future. METHODS SD rats were divided into three groups: blank group, OCMCMS-USPIO-NPs group and dextran-SPIO-NPs group, then iron content in plasma and different tissue including heart, liver, spleen, lung and kidney were determined by atomic absorption spectroscopy. The iron concentration-time in plasma and tissues was drawn. The plasma concentration-time data of iron were analyzed by DAS 2.1.1 statistical software and the main pharmacokinetics parameters was caculated. Statistics analysis combined with Prussian blue staining were used to demonstrate OCMCS-USPIO-NPs and dextran-SPIO-NPs tissue distribution difference in rats. RESULTS There was significant difference between OCMCS-USPIO-NPs group and dextran-SPIO-NPs group in the main pharmacokinetics parameters of iron, including AUC, MRT, tl/2, CL, V2(P〈0.05), the tl/2 in OCMCS-USPIO-NPs group were longer than 7 h in high or low dose group. Compared with dextran-SPIO-NPs group, not only statistical analysis but also Prussian blue staining results indicated the iron content in liver, spleen and lung in OCMCS-USPIO-NPs group were significant lower than dextran-SPIO-NPs. CONCLUSION OCMCS-USPIO-NPs can escape the RES capture to gain longer-circulation time.
出处 《中国现代应用药学》 CAS CSCD 2013年第10期1088-1094,共7页 Chinese Journal of Modern Applied Pharmacy
基金 广东省自然科学基金博士启动项目(S2011040003279) 韶关市科学计划项目[韶科(卫)2011-20] 韶关市卫生局项目(Y11029)
关键词 超小超顺磁氧化铁纳米粒 原子分光光度法 药动学 组织分布 ultrasmall superparamagnetic iron oxide nanoparticles atomic absorption spectroscopy pharmacokinetics tissue distribution
  • 相关文献

参考文献2

二级参考文献15

  • 1吕金荣.微量元素铁与人体健康[J].微量元素与健康研究,2006,23(3):63-64. 被引量:33
  • 2李玉贤,裴晓红.大枣多糖铁(Ⅲ)配合物的合成及一般性质研究[J].中成药,2006,28(5):707-709. 被引量:23
  • 3李蓉生.正常铁代谢及血红蛋白的合成[J].中国全科医学,2006,9(19):1579-1580. 被引量:12
  • 4LONDON E. The molecular formula and structure of the irondextrin complex, Imferon [J ]. H PHarm sci, 2004,939 (7): 1838-1846.
  • 5Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism [J]. Cell, 2004,(117):285 297.
  • 6王宝琴,徐泽平,刘雪红.多糖铁复合物的研究进展[J].安徽农业科学,2007,35(23):7044-7046. 被引量:20
  • 7GUPTA A K, GUPTA M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications [J]. Biomaterials, 2005, 26(18): 3995-4021.
  • 8AGNIHOTRI S A, MALLIKARJUNA N N, AMINABHAVI T M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J]. J Control Release, 2004, 100(1): 5-28.
  • 9ELSABEE M Z, MORSI R E, AL-SABAGH A M. Surface active properties of chitosan and its derivatives [J]. Colloids Surf B B iointerfaces, 2009, 74( 1 ): 1 - 16.
  • 10L1 G Y, HUANG K L, JIANG Y R, et al. Preparation and characterization of carboxyl functionalization of chitosan derivative magnetic nanoparticles [J]. Biochem Eng J, 2008, 40(3): 408-414.

共引文献5

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部